Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
aXichem ABFRA:A6X -12.86%66 Cyclically Adjusted PS Ratio is 21.00 as of Aug. 10, 2026, which is 34% below its 10-year median of 32.01. GuruFocus rates FRA:A6X with a GF Score™ of 66/100 and a GF Value™ of €0.25. Among 1,275 Chemicals companies, aXichem AB ranks worse than 95.37% on this metric.
The historical rank and industry rank for aXichem AB's Cyclically Adjusted PS Ratio or its related term are showing as below:
FRA:A6X'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.33 Med: 32.01 Max: 503.62
Current: 12.98
During the past years, aXichem AB's highest Cyclically Adjusted PS Ratio was 503.62. The lowest was 5.33. And the median was 32.01.
FRA:A6X's Cyclically Adjusted PS Ratio is ranked worse than 95.37% of 1275
companies
in the Chemicals industry
Industry Median: 1.34
vs FRA:A6X: 12.98
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
aXichem AB's adjusted revenue per share data for the three months ended in Mar. 2026 was €0.006. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.01 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
aXichem AB (FRA:A6X) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
aXichem AB Cyclically Adjusted PS Ratio Related Terms
aXichem AB Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for aXichem AB's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:A6X vs LIN, SHW, ECL: Cyclically Adjusted PS Ratio Comparison
For the Specialty Chemicals subindustry, aXichem AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aXichem AB Cyclically Adjusted PS Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, aXichem AB's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where aXichem AB's Cyclically Adjusted PS Ratio falls into.
aXichem AB Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
aXichem AB's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 21.00 mean?
aXichem AB (FRA:A6X) has a Cyclically Adjusted PS Ratio of 21.00 as of Aug. 10, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on aXichem AB and its competitors. This is 34% below median its historical median of 32.01. Over the past decade, aXichem AB's Cyclically Adjusted PS Ratio has ranged from 5.33 to 503.62. According to the industry distribution chart, aXichem AB ranks #1216 out of 1275 companies in the Chemicals industry, placing it in the top 95.4%.
Is aXichem AB's Cyclically Adjusted PS Ratio too high?
aXichem AB's current Cyclically Adjusted PS Ratio of 21.00 is 34% below median its 10-year median of 32.01. Over the past 10 years, this metric has ranged from a low of 5.33 to a high of 503.62. The Chemicals industry median Cyclically Adjusted PS Ratio is 1.34. aXichem AB's value of 21.00 is 1467.2% above this industry median. Based on the distribution chart, aXichem AB ranks #1216 out of 1275 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, aXichem AB has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Cyclically Adjusted PS Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, aXichem AB ranks #1216 out of 1275 companies for Cyclically Adjusted PS Ratio. This places aXichem AB in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.34. aXichem AB's value of 21.00 is 1467.2% above this benchmark. Historically, aXichem AB's own Cyclically Adjusted PS Ratio has ranged from 5.33 to 503.62 over the past decade. While the company's 10-year median is 32.01 vs. the industry median of 1.34, aXichem AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Chemicals company?
The median Cyclically Adjusted PS Ratio among Chemicals companies is 1.34, based on 1,275 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. aXichem AB's current Cyclically Adjusted PS Ratio of 21.00 is 1467.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on aXichem AB and its competitors. For the Chemicals industry, the median Cyclically Adjusted PS Ratio is 1.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current Cyclically Adjusted PS Ratio is 21.00, which is 34% below median its own 10-year median of 32.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current Cyclically Adjusted PS Ratio of 21.00. The stock's GF Value™ is €0.25, compared to a current price of €0.21 — trading 16% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 21.00, which is 34% below median its 10-year median of 32.01 and 1467.2% above the Chemicals industry median of 1.34. aXichem AB's overall GF Score™ is 66/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current Cyclically Adjusted PS Ratio is 21.00 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aXichem AB (FRA:A6X) Overvalued in 2026?
Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued.
The current stock price of €0.21 is trading 16% below its estimated GF Value™ of €0.25.
Key valuation signals for FRA:A6X:
Cyclically Adjusted PS Ratio: 21.00 (34% below median its 10-year median of 32.01)
GF Value™: €0.25 vs. price of €0.21 (16% below fair value)
Industry Position: 1467.2% above the Chemicals median (#1216 of 1275)
No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
66GF Score
Get the complete analysis for FRA:A6X
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A6X has been successfully added to your 
